Worldwide Cancer Research has committed nearly £4 million of
publically raised money to fund 20 new cancer research projects. This
follows decisions made at a “Dragon’s Den” style meeting involving
cancer researchers from all over the world.
Our Chief Executive, Dr Helen Rippon, said: “We are so thankful to
our generous supporters for raising the money we need to support these
pioneering researchers. We are delighted to invest £4 million into some
of the most innovative and exciting research taking place all over the
world. As a charity, we have been funding cancer research for nearly 40
years and we believe that our global search for answers will one day
help stop cancer consuming lives and shattering families.”
The 20 research projects are being carried out in labs all over the
world including the UK, US, Argentina, Europe and Australia and cover
many different types of cancer. The duration of each project is between
two and three years and the type of research to be carried out varies
from drug discovery to understanding what causes cancer and the basic
biology of the disease.
Professor John Spencer, based at the University of Sussex, has
received £187,500, to drive a drug discovery program that aims to
develop a new cancer drug that re-activates a protein called “p53” and
causes cancer cells to die. A further £151,614 has been awarded to Dr
Diego Laderach, based at IQUIBICEN-CONICET in Argentina, allowing him to
start developing an entirely new type of immunotherapy for prostate
cancer.
In Spain, Professor Salvador Aznar-Benitah has been awarded £208,334
to work out how fats in our diet might contribute to the spread of
cancer in oral, skin and breast cancer. While at King’s College London,
Dr Pierre Guermonprez will receive £242,312 to investigate how CRISPR
gene-editing could be used to bolster a person’s immune system in the
fight against cancer.
We rely on public donations - without the support the pioneering projects we fund would simply not happen.